Self-testing is a popular type of in vitro diagnostic medical device used for diagnosing infectious disease

 

Self-testing Market
Self-testing

The In-vitro Diagnostics Directive (EU 98/79/EC) governs the performance of self-testing kits. However, most fall into a lower risk category. In most cases, manufacturers evaluate the analytical performance of the test, but this is not required for most self-testing kits.

There are many self-testing options available. Several COVID-19 testing kits are available over the counter and can be purchased without a prescription. They can be purchased online, at retail stores, or from health care providers. This device is an in vitro diagnostic medical device. It can be used to screen for high blood pressure or cholesterol levels without the assistance of a healthcare professional. The device's high accuracy can be compared to lab results and point-of-care tests with 97% accuracy. These devices are gaining high demand due to its ease of use and accuracy.

The Global Self-Testing Market is estimated to be valued at US$ 18,503.0 million in 2021 and is expected to exhibit a CAGR of 8.5% during the forecast period (2021-2028).

A POC instrument can collect a blood sample from a fingertip in an office or in the comfort of a patient's home. The device can also be used by patients who travel. These devices usually feature a small drop of blood on a test strip. The results are automatically reported to the patient's physician or can be transmitted via Bluetooth. Some of these devices have built-in Bluetooth technology, which allows patients to send their results wirelessly to their healthcare provider. The Hct and Hb values obtained by these device were similar to those of a professional test. The results were not affected by sex, age, or time since diagnosis. The device was easy to use and 92% of patients were satisfied with its results. In addition, the device was easy to use and 99% of patients were willing to start testing at home. This has several important implications for the future of healthcare.

Comments

Post a Comment

Popular posts from this blog

Recycled Construction Aggregates Market Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

Image
  Recycled Construction Aggregates Market Introduction: The Recycled Construction Aggregates Market has gained significant traction in recent years, driven by increasing environmental concerns, resource scarcity, and the growing emphasis on sustainable construction practices. Recycled construction aggregates, derived from the processing and recycling of construction and demolition waste materials, offer several benefits such as reduced demand for virgin materials, decreased landfill waste, and lower carbon footprint. The market for recycled construction aggregates is expected to witness substantial growth and present lucrative opportunities for market players. Market Size and Share: The global recycled construction aggregates market is projected to surpass  6.2 million tons  by the end of 2027 in terms of volume, exhibiting a CAGR of  6.0%  during the forecast period  (2020 to 2027) . The market is driven by stringent environmental regulations, governmen...
Read more

Bispecific Antibodies Are Used As Therapeutic Drugs While Treating Viral Infections, Oncology, And Auto-Immune Diseases

Image
  Bispecific Antibodies Bispecific antibodies are produced through cell fusion or recombinant DNA technologies. Bispecific antibodies are much more specific than monoclonal antibodies. Their applications in tumor immunotherapy are nearly limitless. As of today, seven bispecific antibodies have been approved by the FDA and EMA and over one hundred are in preclinical testing. Bispecific antibodies were initially developed using the quadroma technology. They contain two distinct antigen-binding arms, which enable them to bind to the target antigen while also activating an effector cell, which kills tumor cells. The primary antigen on the surface of the effector cell is called CD3, which is a popular target of immune cells. According to Coherent Market insights the Bispecific Antibodies Market Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028. Many of these multi specific antibody formats have been developed over the past 30 years. These categories ...
Read more

Rising Cancer Cases to boost the Molecular Cytogenetics Market Growth

Image
Molecular Cytogenetics Market Molecular Cytogenetics Market by Products (Kits & Reagents, Instruments, and Software & Services), Technique (Fluorescence in Situ Hybridization, Comparative Genomic Hybridization, Karyotyping, Other Techniques), Application (Cancer, Genetic Disorders, Other Applications), And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 – 2030 The global Molecular Cytogenetics Market is estimated to be valued at US$ 4,211.4 million in 2023, and is expected to exhibit a CAGR of 24.5 % over the forecast period, as highlighted in a new report published by Coherent Market Insights. Market Overview: Clinical cytogenetics is the examination of the relation between chromosomal alterations and genetic disorders in human beings. Molecular cytogenetics is an examination of genetic diseases utilizing new techniques and methods that link cytogenetic and molecular t...
Read more